Update
$OncoCyte (OCX.US)$ Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms2 MINUTES AGO, 4:05 PM ESTVIA GLOBENEWSWIRE • Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population • Study shows that monitoring with Oncocyte's assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies • Early detection of transplant rejection is growing in significance as novel therapeutic treatments show promising early results in antibody mediated rejection. • Study published in Nephrology Dialysis Transplantation
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more